Panacea Acquisition Corp. II (PANA) Stock Forecast, Price & News

Panacea Acquisition Corp. II (NASDAQ:PANA) Frequently Asked Questions

Who are Panacea Acquisition Corp. II's key executives?

Panacea Acquisition Corp. II's management team includes the following people:

• Mr. Oleg Nodelman, Chairman & CEO (Age 45)
• Mr. Scott Eric Perlen, Chief Financial Officer (Age 47)
• Mr. Scott Platshon, Chief Operating Officer (Age 31)
• Ms. Caroline Stout, Chief Investment Officer (Age 31)
• Ms. Sarah Marriott, Sec. & Director (Age 45)

Who are some of Panacea Acquisition Corp. II's key competitors?

Some companies that are related to Panacea Acquisition Corp. II include Gores Holdings VII (GSEV), Churchill Capital Corp VI (CCVI), Warburg Pincus Capital Co. I-B (WPCB), Gores Holdings IX (GHIX), SVF Investment (SVFA), CF Acquisition Corp. IV (CFIV), CION Investment (CION), Churchill Capital Corp V (CCV), Fusion Acquisition Corp. II (FSNB), Mason Industrial Technology (MIT), Landcadia Holdings IV (LCA), E.Merge Technology Acquisition (ETAC), RMG Acquisition Corp. III (RMGC), Trinity Capital (TRIN) and GO Acquisition (GOAC).
View all of PANA's competitors.

When did Panacea Acquisition Corp. II IPO?

(PANA) raised $150 million in an initial public offering on Wednesday, April 7th 2021. The company issued 15,000,000 shares at a price of $10.00 per share. Cowen acted as the underwriter for the IPO.

What is Panacea Acquisition Corp. II's stock symbol?

Panacea Acquisition Corp. II trades on the NASDAQ under the ticker symbol "PANA."

Who are Panacea Acquisition Corp. II's major shareholders?

Panacea Acquisition Corp. II's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Highbridge Capital Management LLC (9.21%), Sculptor Capital LP (4.68%), Glazer Capital LLC (2.37%), Victory Capital Management Inc. (1.43%), Radcliffe Capital Management L.P. (1.08%) and Karpus Management Inc. (0.38%).
View institutional ownership trends for Panacea Acquisition Corp. II.

Which major investors are selling Panacea Acquisition Corp. II stock?

PANA stock was sold by a variety of institutional investors in the last quarter, including Glazer Capital LLC, and Victory Capital Management Inc..
View insider buying and selling activity for Panacea Acquisition Corp. II or view top insider-selling stocks.

Which major investors are buying Panacea Acquisition Corp. II stock?

PANA stock was purchased by a variety of institutional investors in the last quarter, including Highbridge Capital Management LLC, Karpus Management Inc., Radcliffe Capital Management L.P., Sculptor Capital LP, Royal Bank of Canada, and Cohanzick Management LLC.
View insider buying and selling activity for Panacea Acquisition Corp. II or or view top insider-buying stocks.

How do I buy shares of Panacea Acquisition Corp. II?

Shares of PANA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Panacea Acquisition Corp. II's stock price today?

One share of PANA stock can currently be purchased for approximately $9.73.

How much money does Panacea Acquisition Corp. II make?

Panacea Acquisition Corp. II has a market capitalization of $173.19 million.

How many employees does Panacea Acquisition Corp. II have?

Panacea Acquisition Corp. II employs 3 workers across the globe.

What is Panacea Acquisition Corp. II's official website?

The official website for Panacea Acquisition Corp. II is panacea.ecor1cap.com.

How can I contact Panacea Acquisition Corp. II?

Panacea Acquisition Corp. II's mailing address is 357 TEHAMA STREET FLOOR 3, SAN FRANCISCO CA, 94103. The company can be reached via phone at 415-966-0807 or via email at [email protected].